China’s First Medical Devices Innovation Base To Set Up In Chongqing
This article was originally published in PharmAsia News
Executive Summary
China's Ministry of Science and Technology has reached an agreement with Chongqing municipal government to set up an independent national innovation industry base for medical devices. The facility will focus on common problems in the industry by building up a public service platform for fast innovation design, new technology development and application, as well as experimental technology standards. It will also conduct industry, national and international research. After five years, the base is targeted to achieve breakthrough in industrialized core technologies for 50 projects and realize a production value of RMB 50 billion. Chongqing has an edge in independent R&D and innovation within the digital health sector, having developed the world's first high-intensity focused ultrasound tumor therapy system and Asia's first gastrointestinal capsule endoscopy. (Click here for more - Chinese Language)
China's Ministry of Science and Technology has reached an agreement with Chongqing municipal government to set up an independent national innovation industry base for medical devices. The facility will focus on common problems in the industry by building up a public service platform for fast innovation design, new technology development and application, as well as experimental technology standards. It will also conduct industry, national and international research. After five years, the base is targeted to achieve breakthrough in industrialized core technologies for 50 projects and realize a production value of RMB 50 billion. Chongqing has an edge in independent R&D and innovation within the digital health sector, having developed the world's first high-intensity focused ultrasound tumor therapy system and Asia's first gastrointestinal capsule endoscopy. (Click here for more - Chinese Language) "China's First Independent Innovation Medical Device Industry Base Settles In Chongqing" - pharmnet.com.cn (3/4/09) |